<DOC>
	<DOCNO>NCT00520585</DOCNO>
	<brief_summary>The aim study evaluate influence atorvastin repolarisation phase cardiomyocytes . If , could part positive `` non-lipid '' effect statins therapy ischaemic heart disease . Study hypothesis : atorvastin decrease heterogeneity repolarisation cardiomyocytes comparison placebo</brief_summary>
	<brief_title>Study Influence Atorvastatin Repolarisation Phase Cardiomyocytes</brief_title>
	<detailed_description>The group consist 40 healthy volunteer . The study mono-centric . The repolarisation phase cardiomyocytes evaluate use long - term 12-lead digital ECG monitoring . There 3 single ECG recording - randomly 20 mg atorvastin , 80 mg atorvastatin placebo , respectively .</detailed_description>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>sign informed consent age 18 45 year chronic active disease concomitant pharmacotherapy , exclude hormonal contraception abnormal ECG , echocardiography , laboratory finding know hypersensitivity myopathy due statin pregnancy , lactation , breast implant skin disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>atorvastatin</keyword>
	<keyword>repolarisation</keyword>
	<keyword>cardiomyocytes</keyword>
</DOC>